SAMPHIRE NEUROSCIENCE LTD

Executive Summary

Samphire Neuroscience Ltd exhibits strong liquidity and growing net assets, reflecting good financial health despite accumulated losses typical of an early-stage company. The company’s healthy cash reserves and working capital provide a sound foundation for continued growth, though focus on improving profitability is essential. Maintaining strong cash flow management and careful inventory control will support a positive financial trajectory going forward.

View Full Analysis Report →
Company Documents

DateDescription
21/01/2521 January 2025 Notification of a person with significant control statement

View Document

21/01/2521 January 2025 Cessation of Emilė Radytė as a person with significant control on 2024-12-23

View Document

21/01/2521 January 2025 Cessation of Alexander Anthony Cook as a person with significant control on 2024-12-23

View Document

15/01/2515 January 2025 Unaudited abridged accounts made up to 2024-09-30

View Document

08/01/258 January 2025 Memorandum and Articles of Association

View Document

08/01/258 January 2025 Resolutions

View Document

06/01/256 January 2025 Statement of capital following an allotment of shares on 2024-12-13

View Document

30/09/2430 September 2024 Annual accounts for year ending 30 Sep 2024

View Accounts

04/09/244 September 2024 Confirmation statement made on 2024-09-01 with updates

View Document

27/01/2427 January 2024 Resolutions

View Document

27/01/2427 January 2024 Memorandum and Articles of Association

View Document

27/01/2427 January 2024 Resolutions

View Document

27/01/2427 January 2024 Resolutions

View Document

27/01/2427 January 2024 Resolutions

View Document

27/01/2427 January 2024 Resolutions

View Document

24/01/2424 January 2024 Statement of capital following an allotment of shares on 2023-12-21

View Document

21/01/2421 January 2024 Memorandum and Articles of Association

View Document

09/01/249 January 2024 Unaudited abridged accounts made up to 2023-09-30

View Document

24/10/2324 October 2023 Change of details for Mr Alexander Anthony Cook as a person with significant control on 2023-10-24

View Document

30/09/2330 September 2023 Annual accounts for year ending 30 Sep 2023

View Accounts

03/09/233 September 2023 Confirmation statement made on 2023-09-01 with no updates

View Document

29/03/2329 March 2023 Director's details changed for Ms Emilė Radytė on 2022-07-12

View Document

29/03/2329 March 2023 Change of details for Ms Emilė Radytė as a person with significant control on 2022-07-12

View Document

28/03/2328 March 2023 Change of details for Mr Alexander Anthony Cook as a person with significant control on 2021-11-25

View Document

28/03/2328 March 2023 Director's details changed for Mr Alexander Anthony Cook on 2021-11-25

View Document

15/02/2315 February 2023 Unaudited abridged accounts made up to 2022-09-30

View Document

30/09/2230 September 2022 Annual accounts for year ending 30 Sep 2022

View Accounts

01/02/221 February 2022 Certificate of change of name

View Document

30/11/2130 November 2021 Change of details for Mr Alexander Anthony Cook as a person with significant control on 2021-11-24

View Document

30/11/2130 November 2021 Change of details for Ms Emilė Radytė as a person with significant control on 2021-11-24

View Document

30/11/2130 November 2021 Registered office address changed from 3/12 Abbey Road Oxford OX2 0AE England to 85 Great Portland Street First Floor London W1W 7LT on 2021-11-30

View Document

30/11/2130 November 2021 Director's details changed for Ms Emilė Radytė on 2021-11-24

View Document

30/11/2130 November 2021 Director's details changed for Mr Alexander Anthony Cook on 2021-11-25

View Document


More Company Information